Insider Transactions in Q4 2024 at Alector, Inc. (ALEC)
Insider Transaction List (Q4 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 02
2024
|
Gary Romano Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
14,892
-4.09%
|
$29,784
$2.52 P/Share
|
Dec 02
2024
|
Sara Kenkare Mitra President and Head of R&D |
SELL
Open market or private sale
|
Direct |
26,500
-4.48%
|
$53,000
$2.52 P/Share
|
Dec 02
2024
|
Arnon Rosenthal Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
52,172
-2.04%
|
$104,344
$2.52 P/Share
|
Dec 02
2024
|
Marc Grasso Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
16,489
-4.75%
|
$32,978
$2.52 P/Share
|
Oct 01
2024
|
Gary Romano Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
184,380
+33.61%
|
-
|
Oct 01
2024
|
Arnon Rosenthal Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
610,500
+19.26%
|
-
|
Oct 01
2024
|
Sara Kenkare Mitra President and Head of R&D |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+33.64%
|
-
|
Oct 01
2024
|
Marc Grasso Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
216,400
+38.4%
|
-
|